C5AR1 and diabetic kidney disease: Therefore, in this narrative review, we aim to summarize the available data from clinical and preclinical studies that unravel the central role of anaphylatoxin C5a in DKD pathophysiology and turn the spotlight of drug discovery efforts on complement-targeted therapeutics.